BAK1 and gastric cancer: BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel in patients with advanced gastric cancer.499 BAX-BAK heterodimer is also used as a pharmacodynamic biomarker of on-target drug action of MCL1 inhibitors.500